December 19, 2022
Boston Cell Standards obtains FDA approval for its IHControls panel
Continue Reading
December 19, 2022
Regulatory actions for Oct. 6, 2022
Continue Reading
December 19, 2022
FDA clears Boston Cell Standards IHC controls for HER2, ER, PR
Continue Reading
December 19, 2022
Boston Cell Standards nabs FDA clearance for IHC test panel to evaluate breast cancers
Continue Reading
December 19, 2022
Boston Cell Standards Wins First-Ever FDA 510(k) Clearance for Anatomic Pathology Controls
Continue Reading